Indian Drug Makers Fire Back At Rebelling Sales Reps (India)
This article was originally published in PharmAsia News
Executive Summary
Indian drug makers are retaliating against sales representatives who accused them of exploitation and violations of government price caps. The Indian Drug Manufacturers Association, comprising more than 650 medium-size and small drug makers, has asked the Labor minister to reclassify the sales reps as "workmen" rather than as "medical representatives" considered a part of a company's management team. The proposed change is supported by the Organisation of Pharmaceutical Producers of India representing about 100 MNCs and Indian research-based pharmas. The Federation of Medical and Sales Representatives Associations of India also has been trying to get the government to govern their working conditions, such as requiring work days no longer than eight hours. (Click here for more